Baltimore medical device firm developing transseptal access devices for minimally invasive left heart cardiac procedures.
Protaryx Medical Inc. was founded in 2019 and is headquartered in Baltimore, US. It develops transseptal access devices for catheter-based left heart procedures, along with an RF guidewire that works with common electrosurgical generators. It sells to hospitals, cardiac centers and medical distributors, mainly in North America and Europe. David Mester is CEO, and the most recent of its 3 deals was a seed round on June 30, 2020 that raised USD 3.2 mn, bringing the total to USD 5.1 mn.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in